Autonomix Medical Inc. (AMIX)

NasdaqCM: AMIX · Real-Time Price · USD

6.85

-0.01 (-0.15%)

At close: Aug 14, 2026, 3:59 PM

6.80

-0.73%

After-hours: 7:56 PM

-0.15% (1D)

Bid	5.01
Market Cap	3.72M
Revenue (ttm)	n/a
Net Income (ttm)	-16.11M
Beta	n/a
EPS (ttm)	-48.72
PE Ratio (ttm)	n/a
Forward PE	-0.93
P/B (ttm)	1.17
P/S (ttm)	n/a
Earnings Date	n/a

Ask	8.12
Volume	207,963
Avg. Volume (20D)	3,834,806
Open	6.76
Previous Close	6.86
Day's Range	6.27 - 6.99
52-Week Range	2.44 - 32.55
Analyst	n/a
Price Target	58.8 (758.39%)
Dividends	n/a
Ex-Dividend Date	n/a

About AMIX

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chr...

[Read more]

Industry Medical Devices

Sector Healthcare

IPO Date Jan 29, 2024

Employees n/a

Stock Exchange NasdaqCM

Ticker Symbol AMIX

Website https://autonomix.com

Full Company Profile

Financial Performance

In 2026, Autonomix Medical's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -16.71M, an increase of 46.49%.

Financial Statements

Analyst Forecast

According to 2 analyst ratings, the average rating for AMIX stock is "null". The 12-month stock price forecast is 58.8, which is upside of 758.39% from the latest price.

Stock Forecasts